NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

MRK

Merck & Co Inc

May 08 • 04:00PM ET

77.65

Dollar change -1.47
Percentage change -1.86	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE AZN NVS BMY JNJ AMGN ABBV GSK LLY SNY

| Held by: VTI VOO SCHD SPY IVV VTV XLV VIG VYM IWF

Scroll to Statements

Index	DJIA, S&P 500	P/E	11.30	EPS (ttm)	6.87	Insider Own	0.10%	Shs Outstand	2.52B	Perf Week	-6.74%
Market Cap	194.98B	Forward P/E	7.94	EPS next Y	9.78	Insider Trans	-0.13%	Shs Float	2.51B	Perf Month	-1.65%
Income	17.43B	PEG	0.94	EPS next Q	2.06	Inst Own	80.59%	Short Float	1.67%	Perf Quarter	-11.81%
Sales	63.78B	P/S	3.06	EPS this Y	16.55%	Inst Trans	1.05%	Short Ratio	2.43	Perf Half Y	-23.78%
Book/sh	19.21	P/B	4.04	EPS next Y	9.68%	ROA	15.78%	Short Interest	41.93M	Perf Year	-39.13%
Cash/sh	3.72	P/C	20.90	EPS next 5Y	12.07%	ROE	39.31%	52W Range	75.93 - 134.63	Perf YTD	-21.94%
Dividend Est.	3.14 (4.04%)	P/FCF	11.44	EPS past 5Y	12.04%	ROI	21.31%	52W High	-42.32%	Beta	0.45
Dividend TTM	3.16 (4.07%)	Quick Ratio	1.16	Sales past 5Y	7.14%	Gross Margin	74.68%	52W Low	2.27%	ATR (14)	2.60
Dividend Ex-Date	Mar 17, 2025	Current Ratio	1.41	EPS Y/Y TTM	654.93%	Oper. Margin	34.71%	RSI (14)	36.04	Volatility	2.68% 3.35%
Employees	75000	Debt/Eq	0.72	Sales Y/Y TTM	4.40%	Profit Margin	27.33%	Recom	1.82	Target Price	107.05
Option/Short	Yes / Yes	LT Debt/Eq	0.69	EPS Q/Q	7.20%	Payout	46.32%	Rel Volume	0.87	Prev Close	79.12
Sales Surprise	1.24%	EPS Surprise	4.09%	Sales Q/Q	-1.20%	Earnings	Apr 24 BMO	Avg Volume	17.26M	Price	77.65
SMA20	-3.24%	SMA50	-10.08%	SMA200	-22.71%	Trades		Volume	15,046,849	Change	-1.86%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$85
Feb-18-25	Downgrade	Deutsche Bank	Buy → Hold	$128 → $105
Feb-10-25	Downgrade	TD Cowen	Buy → Hold	$121 → $100
Jan-08-25	Downgrade	Truist	Buy → Hold	$110
Dec-20-24	Downgrade	BMO Capital Markets	Outperform → Market Perform	$136 → $105
Dec-10-24	Resumed	BofA Securities	Buy	$121
Dec-04-24	Upgrade	HSBC Securities	Hold → Buy	$130
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Nov-11-24	Downgrade	Daiwa Securities	Buy → Neutral
Oct-17-24	Initiated	Bernstein	Mkt Perform	$115
Mar-11-24	Downgrade	Societe Generale	Hold → Sell	$104
Jan-04-24	Upgrade	TD Cowen	Market Perform → Outperform	$125 → $135
Nov-09-23	Initiated	Deutsche Bank	Buy	$115
Oct-27-23	Upgrade	BMO Capital Markets	Market Perform → Outperform	$132
Oct-20-23	Upgrade	UBS	Neutral → Buy	$117 → $122
Jul-14-23	Initiated	HSBC Securities	Hold	$123
Apr-13-23	Upgrade	Citigroup	Neutral → Buy	$105 → $130
Mar-28-23	Downgrade	Societe Generale	Buy → Hold
Mar-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$120 → $115
Mar-06-23	Initiated	Jefferies	Buy	$125

Show Previous Ratings

May-08-25 11:50AM	A Look at Pharma ETFs After Strong Q1 Earnings (Zacks)
09:12AM	2 Beaten-Down Stocks That Are Great Buys on the Dip (Motley Fool)
06:45AM	Merck Animal Health and State of Kansas Announce $895 Million Investment in Manufacturing and Research & Development Facilities in De Soto (Business Wire)
May-07-25 04:55PM	Is Merck & Co., Inc. (MRK) the Best Dow Stock? (Insider Monkey)
04:51PM	Trump planning on Executive Order to further cut Medicare drug prices - report (Seeking Alpha)
11:06AM	Loading…
11:06AM	Merck & Co., Inc. (MRK): A Bull Case Theory (Insider Monkey)
09:26AM	Stock Market News for May 7, 2025 (Zacks)
08:25AM	Merck & Co., Inc. (MRK): Among Billionaire Mario Gabelli's Large-Cap Stock Picks with Huge Upside Potential (Insider Monkey)
06:45AM	Merck to Participate in the Bank of America 2025 Global Healthcare Conference (Business Wire)
04:55AM	Fidelity Select Health Care Portfolio Q1 2025 Commentary (Seeking Alpha)
May-06-25 11:42AM	Why A Short Strangle Trade Might Be Best For Volatile Stocks Like Merck (Investor's Business Daily)
09:54AM	Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1 (Zacks)
May-05-25 11:00AM	Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now? (Insider Monkey)
07:42AM	Franklin Income SMA Q1 2025 Commentary (Seeking Alpha)
06:20AM	Should Invesco Dow Jones Industrial Average Dividend ETF (DJD) Be on Your Investing Radar? (Zacks)
05:06AM	Loading…
05:06AM	I Scanned The S&P 500 For GARP Stocks; Here's What I Found (Seeking Alpha)
May-03-25 09:46AM	Dogs Of The Dow Chase May's 'Safer' Buy (Seeking Alpha)
08:30AM	5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (May 2025) (Seeking Alpha)
04:15AM	Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? (Motley Fool)
May-02-25 10:00AM	Why The Low Payout Ratio Did Not Stop The Dividend Cut For Organon (Seeking Alpha)
09:01AM	Summit Therapeutics Q1 Loss Narrower Than Expected, Sales Nil (Zacks)
05:07AM	Inhibikase Therapeutics: A Hold With Uncertain Prospects In PAH (Seeking Alpha)
May-01-25 10:23PM	Top 10 High-Yield Dividend Stocks To Consider In May 2025 (Seeking Alpha)
05:23PM	Merck & Co., Inc. (MRK): Jim Cramer Agrees - "Merck's A Good Company" (Insider Monkey)
11:51AM	LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down (Zacks)
11:22AM	Moderna Beats on Q1 Earnings, Lags on Revenues, Focuses on Cost Cuts (Zacks)
09:06AM	Halozyme Therapeutics: Still Undervalued Ahead Of Earnings (Seeking Alpha)
09:00AM	Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know (Zacks)
08:00AM	Arvinas, Entrada cut staff; Merck builds US hub for Keytruda (BioPharma Dive)
Apr-30-25 02:25PM	Is Merck & Co. Inc. (MRK) the Best Dow Stock for the Next 12 Months? (Insider Monkey)
11:18AM	Loading…
11:18AM	Merck & Co., Inc. (MRK): Among Billionaire Cliff Asness' Stock Picks with Huge Upside Potential (Insider Monkey)
10:00AM	Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now (Motley Fool)
09:09AM	Should You Buy, Sell or Hold GILD Stock Post Q1 Earnings Miss? (Zacks)
05:41AM	Construction begins on MSDs $1bn biologics centre in Delaware, US (Pharmaceutical Technology)
05:17AM	3 Names I Picked Up In The Latest Market Slump (Seeking Alpha)
Apr-29-25 12:11PM	How To Put $100 In Your Retirement Fund Each Month With Merck Stock (Benzinga)
10:31AM	Pfizer offers 'longer-term' opportunity amid tariff uncertainty (Yahoo Finance Video)
10:27AM	Is Merck & Co., Inc. (MRK) the Worst-Performing Blue Chip Stock So Far in 2025? (Insider Monkey)
09:42AM	Stocks to Watch Tuesday: UPS, Spotify, PayPal, BP (The Wall Street Journal)
09:12AM	AZN Q1 Earnings Beat, Stock Down on Soft Sales Performance of Key Drugs (Zacks)
06:45AM	Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware (Business Wire)
05:30AM	Merck to Spend $1 Billion on New Factory to Make U.S. Supplies of Blockbuster Drug (The Wall Street Journal)
Apr-28-25 12:17PM	Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion (Benzinga)
11:16AM	Jim Cramer Says Merck & Co (MRK) Has 'Turned Into a Complete Nightmare' (Insider Monkey)
10:35AM	Temu, Tesla prices, Merck KGaA deal: Trending Tickers (Yahoo Finance Video)
09:19AM	Is Merck & Co., Inc. (MRK) the Most Profitable Blue Chip Stock to Buy Now? (READY TO EDIT2) (Insider Monkey)
09:19AM	Is Merck & Co., Inc. (MRK) the Most Profitable Blue Chip Stock to Buy Now? (Insider Monkey)
09:18AM	BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
08:31AM	2 Must-Own Dividends At Bargain Basement Prices (Seeking Alpha)
07:48AM	Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat? (Zacks)
03:07AM	Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings (StockStory)
Apr-27-25 03:08PM	Merck & Co., Inc. (MRK): Among Billionaire Ken Fisher's Healthcare Stock Picks with Massive Upside Potential (Insider Monkey)
12:00PM	KEYTRUDA (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (Business Wire)
09:22AM	Immunocore Holdings: A Name On My Watch List (Seeking Alpha)
07:00AM	Wall Streets New Tariff Safe Haven: High-Tax Biotech Stocks (The Wall Street Journal)
Apr-26-25 02:32PM	2 Outstanding Dividend Stocks to Buy and Hold For 20 Years (Motley Fool)
12:50PM	Akeso survival data for ivonescimab misses expectations, STAT says (TipRanks)
09:30AM	Summit Therapeutics: New Ivonescimab Data Raise Concerns (Seeking Alpha)
Apr-25-25 04:00PM	AbbVie: Q1 Earnings Reinforce Positive Momentum (Seeking Alpha)
11:57AM	Can Moderna Keep the Beat Streak Alive This Earnings Season? (Zacks)
09:25AM	Company News for Apr 25, 2025 (Zacks)
06:34AM	Halozyme sues Merck; FDA blames cuts for Vanda delay (BioPharma Dive)
12:49AM	Q1 2025 Merck & Co Inc Earnings Call (Thomson Reuters StreetEvents)
Apr-24-25 05:24PM	Stocks to Watch Recap: Alphabet, Intel, P&G, Merck (The Wall Street Journal)
04:08PM	Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan (Investor's Business Daily)
02:20PM	Merck Q1 Earnings & Sales Beat Estimates, '25 EPS Outlook Cut (Zacks)
02:01PM	Merck & Co., Inc. (MRK) Q1 2025 Earnings Call Transcript (Seeking Alpha)
02:01PM	Analyst Report: Merck & Co., Inc. (Morningstar Research)
01:20PM	Merck warns of big tariff hit, Hasbro soars, Comcast sinks (Yahoo Finance Video)
12:05PM	Merck Cuts 2025 Outlook on Tariffs, Charges (The Wall Street Journal)
11:22AM	Bristol-Myers Q1 Earnings Review: A Decidedly Mixed Bag - Rating Downgrade (Seeking Alpha)
10:30AM	Merck (MRK) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
10:19AM	Stocks to Watch Thursday: P&G, IBM, Merck, ServiceNow (The Wall Street Journal)
09:37AM	Merck, Nokia, Texas Instruments: Trending Tickers (Yahoo Finance Video)
07:43AM	Merck takes $200M tariff hit, trimming its gross profits (BioPharma Dive)
07:40AM	Merck (MRK) Q1 Earnings and Revenues Top Estimates (Zacks)
07:07AM	Merck's (NYSE:MRK) Q1 Sales Beat Estimates (StockStory)
06:59AM	Merck Trims FY25 Adj. EPS Outlook - Update (RTT News)
06:40AM	Merck: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	Merck Stock Takes A Hit As Gardasil 'Woes' Continue In China, Japan (Investor's Business Daily)
06:30AM	Gardasil Sales Decline Again. Can Dow Jones Stock Merck Take The Hit? (Investor's Business Daily)
06:30AM	Merck Announces First-Quarter 2025 Financial Results (Business Wire)
Apr-23-25 07:00PM	Alphabet earnings, Fed comments, Nintendo Switch 2: What to Watch (Yahoo Finance Video)
04:10PM	BioNTech Surges On Summit's Coattails. But Can They Take On Merck? (Investor's Business Daily)
02:50PM	Why vaccine makers aren't worried about Trump administration cuts (Yahoo Finance)
01:08PM	Is Merck & Co., Inc. (MRK) the Best Stock To Buy According to Marjorie Taylor Greene? (Insider Monkey)
09:25AM	The Zacks Analyst Blog Highlights Gilead Sciences, Bristol Myers, Merck, AbbVie and Sanofi (Zacks)
08:02AM	Merck (MRK) Reports Q1: Everything You Need To Know Ahead Of Earnings (StockStory)
Apr-22-25 09:01PM	Merck & Co., Inc. (MRK): Among Prem Watsa's Stock Picks With Highest Potential (Insider Monkey)
09:06AM	Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast? (Zacks)
07:32AM	Merck Q1 Earnings Coming Up: Should You Buy the Stock Now? (Zacks)
07:09AM	Iovance Biotherapeutics: Only For The Brave (Seeking Alpha)
07:00AM	Health Canada Approves KEYTRUDA® Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Adult Patients with Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma (MPM) (PR Newswire)
Apr-21-25 09:33PM	Merck: Now A Single-Digit P/E With Double-Digit EPS Growth, Technical Support (Seeking Alpha)
11:14AM	Merck & Co.: Pipeline Resilience To Unlock Value (Seeking Alpha)
08:17AM	Strength Seen in Lilly (LLY): Can Its 14.3% Jump Turn into More Strength? (Zacks)
Apr-20-25 05:52AM	Wall Street Week Ahead (Seeking Alpha)
Apr-19-25 11:44AM	Merck & Co., Inc. (MRK): Among Value Stocks in Ken Fisher's Portfolio (Insider Monkey)
11:00AM	Tesla, Google To Report Earnings As Investors Watch Out For Consumer Confidence, Jobless Claims (Seeking Alpha)
11:00AM	Tesla, Amazon To Report Earnings As Investors Watch Out For Consumer Confidence, Jobless Claims (Seeking Alpha)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Smart Dalton E. III	SVP Fin. - Global Controller	May 03 '25	Option Exercise	83.18	2,050	170,519	10,127	May 05 04:23 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 30 '25	Option Exercise	84.71	464	39,305	8,242	May 02 04:18 PM
Smart Dalton E. III	SVP Fin. - Global Controller	May 02 '25	Option Exercise	83.26	381	31,722	8,464	May 02 04:18 PM
Romanelli Joseph	President, Human Health Int?l	May 02 '25	Option Exercise	83.26	2,262	188,334	24,061	May 02 04:14 PM
Romanelli Joseph	President, Human Health Int?l	Apr 30 '25	Option Exercise	84.71	2,063	174,757	22,816	May 02 04:14 PM
Larson Betty D	EVP, Chief HR Officer	Apr 30 '25	Option Exercise	84.71	11,350	961,458	11,350	May 02 04:12 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 25 '25	Option Exercise	58.08	5,000	290,400	12,040	Apr 29 04:04 PM
Smart Dalton E. III	SVP Fin. - Global Controller	Apr 25 '25	Sale	82.76	4,262	352,723	7,778	Apr 29 04:04 PM
DALTON SMART	Officer	Apr 25 '25	Proposed Sale	82.76	4,262	352,723		Apr 25 04:05 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 19 '25	Sale	84.09	8,500	714,745	30,705	Feb 20 04:01 PM
JOHANNES JACOBUS OOSTHUIZEN	Officer	Feb 19 '25	Proposed Sale	84.09	8,500	714,745		Feb 19 05:09 PM
DAVID WILLIAMS	Officer	Feb 13 '25	Proposed Sale	85.34	6,000	512,057		Feb 13 04:10 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 13 '25	Sale	85.34	6,000	512,057	24,123	Feb 13 04:01 PM
Oosthuizen Johannes Jacobus	President, U.S. Market	Feb 08 '25	Option Exercise	87.28	13,002	1,134,815	45,609	Feb 11 02:59 PM
THULIN INGE G	Director	Feb 06 '25	Buy	88.25	2,833	250,000	2,933	Feb 07 04:09 PM
Downing Cristal N	Chief Comm. & Public Afrs Ofcr	Feb 06 '25	Sale	88.76	2,361	209,551	7,085	Feb 07 04:07 PM
BAKER DOUGLAS M JR	Director	Feb 05 '25	Buy	88.50	15,000	1,327,500	16,000	Feb 07 04:04 PM
CRISTAL DOWNING	Officer	Feb 06 '25	Proposed Sale	88.76	2,361	209,551		Feb 06 04:43 PM
Guindo Chirfi	Chief Marketing Officer	Aug 05 '24	Option Exercise	115.20	36,901	4,250,995	57,782	Aug 06 12:20 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRK

Merck & Co Inc

Upgrade your FINVIZ experience